Cytotoxicity, Immunologic
"Cytotoxicity, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.
Descriptor ID |
D003602
|
MeSH Number(s) |
G12.287
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cytotoxicity, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Cytotoxicity, Immunologic".
This graph shows the total number of publications written about "Cytotoxicity, Immunologic" by people in this website by year, and whether "Cytotoxicity, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Cytotoxicity, Immunologic" by people in Profiles.
-
Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas. J Immunother. 2012 Oct; 35(8):629-40.
-
Human immune reactivity against liver sinusoidal endothelial cells from GalTa(1,3)GalT-deficient pigs. Cell Transplant. 2010; 19(6):783-9.
-
Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer. Lung Cancer. 2002 Apr; 36(1):17-25.
-
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol. 1997 Aug; 78 ( Pt 8):1907-11.
-
Natural killer cell cytotoxicity and the multidrug resistance gene. Transplant Proc. 1993 Feb; 25(1 Pt 1):96-7.
-
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother. 1993; 36(2):133-9.
-
Activation of complement on the surface of cells infected by human immunodeficiency virus. J Immunol. 1990 Feb 15; 144(4):1490-6.
-
Studies of connective tissue mast cell-mediated cytotoxicity. J Invest Dermatol. 1989 Sep; 93(3):423-8.
-
Increase in proliferation and cytotoxic cell development in human mixed lymphocyte cultures in the presence of very low concentrations of LPS: role of IL-1 and prostaglandin E2. Clin Immunol Immunopathol. 1986 Jan; 38(1):32-46.
-
Specific cytotoxicity of human lymphocyte subpopulations defined by bacterial adherence. Clin Exp Immunol. 1985 Aug; 61(2):450-8.